Invus
New York-based multi-strategy investment firm with $10B+ AUM, partnering long-term with entrepreneurs across private equity, growth tech, and life sciences.
New York, United States · 81+ investments · 79 portfolio companies
- Headquarters
- New York, United States
- Founded
- 1985
- Website
- invus.com
- AUM
- $10.0B
- Portfolio Companies
- 79
- Total Investments
- 81
- Last Investment
- Dec 2025
- Geographic Focus
- Europe, Global, United States, Asia
Indexed holds 79 portfolio companies and 81 funding rounds for this investor. The full record is or through the API.
Investment Thesis
Invus is a Venture Capital firm based in New York, United States. It has made 81 investments, including Edgewise Therapeutics, Hemab Therapeutics and MOMA Therapeutics. Focus areas include Biotech and Digital Health.
Portfolio79
Showing 48 of 79 recorded portfolio companies.
Co-investors24
Sign up to view co-investors
24 co-investors across 133 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×16 · Hedge Fund ×4 · Other ×3 · 81 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/invus"><img src="https://indexed.vc/api/badge/investor/invus" alt="Invus on Indexed.vc" width="260" height="76" /></a>